Autoimmune disorders: A concept of treatment based on mechanisms of disease

Springer Seminars in Immunopathology

Volumn 25, Issue SUPPL. 1, 2003, Pages

  Miescher, Peter A ^a   Zavota, Laura ^b   Ossandon, Alejandra ^c   Lagana, Bruno ^c  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AUTOANTIBODY; AUTOANTIGEN; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DANAZOL; DAPSONE; EFALIZUMAB; ETANERCEPT; EVEROLIMUS; FINGOLIMOD; HLA DR4 ANTIGEN; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; LEVAMISOLE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MERCAPTOPURINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLAMINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; SALAZOSULFAPYRIDINE; TACROLIMUS; THALIDOMIDE; UNINDEXED DRUG;

ALOPECIA; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; APOPTOSIS; ASEPTIC NECROSIS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; B LYMPHOCYTE; BLADDER IRRITATION; BONE MARROW TOXICITY; CARCINOGENICITY; CATARACT; CELLULAR IMMUNITY; CLINICAL TRIAL; COLLAGEN DISEASE; COMPLEMENT ACTIVATION; CORNEA DISEASE; CUSHING SYNDROME; CYTOTOXIC T LYMPHOCYTE; DISEASE EXACERBATION; DRUG CHOICE; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG TOLERABILITY; ERYTHEMA; FLU LIKE SYNDROME; GASTROINTESTINAL TOXICITY; GENETIC PREDISPOSITION; GINGIVA HYPERPLASIA; GROWTH RETARDATION; HEPATITIS C VIRUS; HIRSUTISM; HISTORY OF MEDICINE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERURICEMIA; IMMUNE RESPONSE; INFECTION SENSITIVITY; LEUKOPENIA; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MIMICRY; MUCOSA INFLAMMATION; MULTIPLE SCLEROSIS; NEPHROTOXICITY; NEUTROPENIA; OSTEOPOROSIS; PAIN; PATHOGENESIS; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RETINOPATHY; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; SKIN MANIFESTATION; STRESS; SUPPRESSOR CELL; T LYMPHOCYTE; TASTE DISORDER; WATER RETENTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AUTOIMMUNE DISEASES; HUMANS;

EID: 0346331457     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-003-0151-1     Document Type: Review

References (72)

1. Von Behring E, Kitisato SH (1890) Serotherapie mit anti-diphterie serum. Dtsch Med Wochenschr 16:1113
2. Metalnikoff S (1900) Etudes sur la spermatoxine. Ann Inst Pasteur (Paris)14:577
3. Chauffard MA, Vincent C (1909) Hémoglobinurie hé molysinique avec ictère polycholique aigu. Semin Med 29:601
4. Fiessinger N (1908) Des anticorps hépatiques chez les sujets atteints de cirrhose en évolution. J Physiol Pathol Gen 10:671
5. Bordet J, Gengou O (1901) Sur l'existence de substances sensibilisatrices dans la plupart des sérums anti-microbies. Ann Inst Pasteur (Paris) 15:289
6. Fagraeus A (1948) Antibody production in relation to the development of plasma cells: in vivo and in vitro experiments. Acta Med Scand Suppl 204:3
7. Glick B, Chang TS, Jaap RG (1956) The bursa of Fabricius and antibody production. Poultry Sci 35:224
8. Chase MW (1945) The cellular transfer of cutaneous hypersensitivity to tuberculin Proc Soc Exp Biol Med 59:134
9. Benacerraf G, Gell PGH (1961) Immunological specificity of delayed and immediate hypersensitivity reaction. In: Proceedings of the Second International Symposium on Immunopathology. Schwabe, Basle, p 136
10. Miller JFAP (1961) The immunological function of the thymus. Lancet 11:748
11. Good RA, Dalmasso AP, Martinez C, Archer OK, Pierce JC, Papermaster BW (1962) The role of the thymus in development of immunologic capacity in rabbits and mice. J Exp Med 116:773
12. Benacerraf B, McDevitt HO (1972) The histocompatibility linked immune response genes. Science 175:273
13. Zinkernagel RM, Doherty PC (1975) H2 compatibility requirement for T cell mediated lysis of target cells infected with lymphocytic choriomeningitis virus. J Exp Med 116:773
14. Mosmann TR, Coffman RL (1989) Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145
15. Billingham RE, Brent L, Medawar PB (1953) Actively acquired tolerance of foreign cells. Nature 172:603
16. Gorer PA (1955) The antibody response to skin homografts in mice. Ann N Y Acad Sci 59:365
17. Miescher PA, Fauconnet M (1954) Mise en évidence de différents groupes leucocytaires chez l'Homme. Schweiz Med Wochenschr 84:597
18. Dausset J (1958) Iso-leuko-antibodies. Vox Sang 13:40
19. Mouzaki A, Theodoropoulou M, Gianakopoulos I, Vlaha V, Kyrsonis M-C, Maniatis A (2002) Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura. Blood 100:1774
20. Coombs RRA, Mourant AE, Race RR (1945) Detection of incomplete Rhesus agglutinins. A new test. Lancet II:15
21. Klemperer P, Pollack AD, Baehr G (1942) The concept of collagen disease. JAMA 119:331
22. Hargraves MM, Richmond H, Morton R (1948) Presentation of two bone marrow elements: the "Tart" cell and the "LE" cell. Mayo Clin Proc 23:25
23. Miescher PA, Fauconnet M (1954) L'absorption du facteur "LE" par des noyaux cellulaires isolés. Experientia 10:252
24. Miescher PA, Straessle R (1957) New serological methods for the detection of the LE factor. Vox Sang 2:283
25. Holman H, Kunkel HG (1957) Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein. Science 126:162
26. Waaler E (1940) On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. Acta Pathol Microbiol Scand 17:172
27. Rose HM, Ragan C, Pearce E, Lipman MO (1948) Differential agglutination of normal and sensitised sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc Soc Exp Biol NY 68:1
28. Weyand CM, Klimink PA, Goronzy JJ (1993) Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes. Springer Semin Immunopathol 20:5
29. Shen HH, Winchester RJ (1986) Susceptibility genetics of SLE. Springer Semin Immunopathol 9:143
30. Opie LE (1924) Acute inflammation caused by antibody in an animal previously treated with antigen. The relation of antigen to antibody in the arthus phenomenon. J Immunol 9:255
31. Germuth FG, McKinnon GE (1957) Studies of the biological properties of antigen-antibody complexes in unsensitised normal guinea-pigs. Johns Hopkins Hosp Bull 101:13
32. Dixon FJ, Vazquez JJ, Weigle WO, Cochrane CG (1958) Pathogenesis of serum sickness. AMA Arch Pathol 65:18
33. Miescher PA, Straessle R, Neukom S (1954) Etude de la réaction antigène-anticorps dans le sang au moyen d'un antigène marqué. Helv Med Acta 21:392
34. Mellors RC, Ortega LG, Holman ER (1957) Role of gammaglobulins in pathogenesis of renal lesions in SLE. J Exp Med 106:191
35. Strand V (2001) New therapies in development for autoimmune diseases: their rationale for combination treatment. Springer Semin Immunopathol 23:43
36. Aho K, Koskenvuo M, Tuominen J, Kaprio J (1986) Occurence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 13:899-902
37. Stastny P (1978) Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 298:869-871
38. Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH (2002) Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 31:355-360
39. Ramos M, De Castro JA (2002) HLA-B27 and the pathogenesis of spondyloarthritis. Tissue Antigens 60:191-205
40. Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR (1999) Behcet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54:213-220
41. Weyand CM, McCarthy TG, Goronzy JJ (1995) Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 95:2120-2126
42. Barilla-LaBarca ML, Atkinson JP (2003) Rheumatic syndromes associated with complement deficiency. Curr Opin Rheumatol 15:55-60
43. Walport MJ (2001) Complement. II. N Engl J Med 344:1140-1144
44. Vogel A, Manns MP, Strassburg CP (2002) Autoimmunity and viruses. Clin Liver Dis 6:45-465
45. Ferricci C, Zignego AL (2000) Relation between infection and autoimmunity in mixed cryoglobulinemia. Curr Opin Rheumatol 12:53-60
46. Massa M, Mazzoli F, Pignatti P, De Benedetti F, Passalia M, Viola S, Samodal R, La Cava A, Giannoni F, Ollier W, Martini A, Albani S (2002) Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis. Arthritis Rheum 46:2721-2729
47. Ebringer A, Wilson C (2000) HLA molecules, bacteria and autoimmunity. J Med Microbiol 49:305-311
48. Theofilopoulos AN (1995) The basis of autoimmunity. I. Mechanisms of aberrant self-recognition. Immunol Today 16:90-98
49. Van den Steen PE, Proost P, Grillet B, Brand DD, Kang AH, Van Damme J, Opdenakker G (2002) Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J 16:379-389
50. Jackson CE, Puck JM (1999) Autoimmune lymphoproliferative syndrome: a disorder of apoptosis Curr Opin Pediatr 11:521-527
51. Utz PJ, Anderson P (1998) Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum 41:1152-1160
52. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR (1998) Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41:1241-1250
53. Wu X, Molinaro C, Johnson N, Casiano CA (2001) Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens. Arthritis Rheum 44:2642-2652
54. Nishikawa Y, Shibata R, Ozono Y, Ichinose H, Miyazaki M, Harada T, Kohno S (2000) Streptococcal M protein enhances TGF-beta production and increases surface IgA-positive B cells in vitro in IgA nephropathy. Nephrol Dial Transplant 15:772-777
55. Van Heel DA, McGovern DP, Jewell DP (2001) Crohn's disease: genetic susceptibility, bacteria, and innate immunity. Lancet 357:1902-1904
56. Fitzpatrick R, Newman S, Lamb R, Shipley M (1988) Social relationships and psychological well-being in rheumatoid arthritis. Soc Sci Med 27:399-403
57. McCarty MF (2001) Upregulation of lymphocyte apoptosis as a strategy for preventing and treating autoimmune disorders: a role for whole food vegan diets, fish oil and dopamine agonists. Med Hypotheses 57:258-275
58. Brown AC (2000) Lupus erythematosus and nutrition: a review of the literature. J Ren Nutr 10:170-183
59. Lawley W, Doherty A, Denniss S, Chauhan D, Pruijn G, van Venrooij WJ, Lunec J, Herbert K (2000) Rapid lupus autoantigen relocalization and reactive oxygen species accumulation following ultraviolet irradiation of human keratinocytes. Rheumatology (Oxf) 39:253-261
60. Bennion SD, Morris DA (1997) Ultraviolet light modulation of autoantigens, epidermal cytokines and adhesion molecules as contributing factors of the pathogenesis of cutaneous LE. Lupus 6:181-192
61. Klosner G, Trautinger F, Knobler R, Neuner P (2001) Treatment of peripheral blood mononuclear cells with 8-methoxypsoralen plus ultraviolet A radiation induces a shift in cytokine expression from a Th1 to a Th2 response. J Invest Dermatol 116:459-462
62. Harrison BJ (2002) Influence of cigarette smoking on disease outcome in rheumatoid arthritis. Curr Opin Rheumatol 14:93-97)
63. Herrick AL, Matucci-Cerinic L (2001) The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin Exp Rheumatol 19:4-8
64. Mok CC, Lau CS, Wong RWS (2001) Use of exogenous estrogens in systemic lupus erythematosus. Semin Arthritis Rheum 30:426-435
65. Buyon JP (1998) Hormone replacement therapy in postmenopausal women with systemic lupus erythematosus. J Am Med Womens Assoc 53:13-17
66. Hall GM, Daniels M, Huskisson EC, Spector TD (1994) A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Ann Rheum Dis 53:112-116
67. Beris P, Burger A, Favre H, Riondel A, Miescher PA (1986) Adrenocortical responsiveness after discontinuous corticosteroid therapy. Klin Wochenschr 64:70
68. Spiegelberg HL, Miescher PA (1963) The effect of 6-mercaptopurine and methotrexate on experimental immune thyroiditis in guinea pigs. J Exp Med 118:869
69. Miescher PA (1986) 20 years of methotrexate in the treatment of autoimmune diseases. Rheumatology (Oxf) 9:46
70. Miescher PA, Favre H, Lemoine R, Huang YP (1994) Drug combination therapy of systemic lupus erythematosus. Springer Semin Immunopathol 16:295
71. Valesini G, Priori R, Francia A, Tincani A, Airo P, Cattaneo A, Zambruni B, Troianello B, Chofflon M, Miescher PA (1994) Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate. Springer Semin Immunopathol 16:313
72. Manzotti F, Orsoni JG, Zavota L, Cimino L, Zola E, Bonaguri C (2002) Autoimmune uveitis in children: clinical correlation between antinuclear antibody positivity and ocular recurrences. Rheumatol Int 21:127